Live from the NIH registry
Studies recruiting near Santa Clarita right now
Top 25 of 2,389 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Kaiser Permanente - Panorama City — Panorama City, California (13.6 mi)
· Sponsor: SWOG Cancer Research Network
Assessing Improvements in Mood and Sleep Trial
Depression, Suicidality
N/A
Interventional 420 participants sought
The Regents of the University of California, Los Angeles — Los Angeles, California (29.1 mi)
· Sponsor: University of Pittsburgh
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
UCLA Care — Los Angeles, California (29.1 mi)
· Sponsor: Westat
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Beverly Hills Cancer Center — Beverly Hills, California (24.4 mi)
· Sponsor: Relay Therapeutics, Inc.
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
California Eye Specialists Medical group Inc. — Pasadena, California (27.4 mi)
· Sponsor: Genentech, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital Los Angeles — Los Angeles, California (29.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Migraine
Phase 2
Interventional 488 participants sought
Clinical Research Institute, LCC — Los Angeles, California (29.1 mi)
· Sponsor: AbbVie
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Narcolepsy Type 1
Phase 3
Interventional 150 participants sought
Alkermes Investigational Site — Los Angeles, California (29.1 mi)
· Sponsor: Alkermes, Inc.
Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial
Prostate Adenocarcinoma, Stage II Prostate Cancer AJCC v8
Phase 2
Interventional 95 participants sought
UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California (29.1 mi)
· Sponsor: Jonsson Comprehensive Cancer Center
PEACE Trial: Postpartum Evaluation of Antihypertensive Cessation and Efficacy
Postpartum Hypertension (PPHT)
Phase 4
Interventional 110 participants sought
UCLA Ronald Reagan — Los Angeles, California (29.1 mi)
· Sponsor: University of California, Los Angeles
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Solid Tumor, Non-Small-Cell Lung Cancer
Phase 1
Interventional 364 participants sought
UCLA Santa Monica Hematology Oncology — Santa Monica, California (27.5 mi)
· Sponsor: Astellas Pharma Inc
Developing an Innovative Decision Support Tool for Pediatric Neuromuscular Scoliosis
Children With Medical Complexity (CMC), Multiple Chronic Conditions
N/A
Interventional 110 participants sought
Children's Hospital Los Angeles — Los Angeles, California (29.1 mi)
· Sponsor: University of Utah
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Amyotrophic Lateral Sclerosis
Phase 3
Interventional 495 participants sought
University of Southern California — Los Angeles, California (29.1 mi)
· Sponsor: AB Science
Housing Transitions QUERI
Homelessness
Phase 1
Interventional 153 participants sought
VA Greater Los Angeles Healthcare System, West Los Angeles, CA — West Los Angeles, California (25.9 mi)
· Sponsor: VA Office of Research and Development
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
Hepatocellular Carcinoma
Phase 1, Phase 2
Interventional 304 participants sought
Research Site — Los Angeles, California (29.1 mi)
· Sponsor: AstraZeneca
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Sylmar, California (8.0 mi)
· Sponsor: AstraZeneca
Exploring, Predicting, and Intervening on Long-term Viral Suppression Electronically
HIV Infections
N/A
Interventional 1,000 participants sought
University of California, Los Angeles — Los Angeles, California (29.1 mi)
· Sponsor: University of California, Los Angeles
Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)
Colorectal Cancer Metastatic
Phase 2
Interventional 20 participants sought
USC/Norris Cancer Center — Los Angeles, California (29.1 mi)
· Sponsor: Buzzard Pharmaceuticals
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 2
Interventional 168 participants sought
Academic Medical Research Institute — Los Angeles, California (29.1 mi)
· Sponsor: R1 Therapeutics
Automated Insulin for Management of Intrapartum Glycemia
Type 1 Diabetes (T1D), Pregnancy
N/A
Interventional 150 participants sought
University of California, Los Angeles — Los Angeles, California (29.1 mi)
· Sponsor: University of California, San Francisco
Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
Glioblastoma Multiforme
Phase 1, Phase 2
Interventional 10 participants sought
Cedars-Sinai Medical Center — Los Angeles, California (29.1 mi)
· Sponsor: Chirag G. Patil
Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer
Renal Pelvis and Ureter Urothelial Carcinoma
Phase 2
Interventional 21 participants sought
UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California (29.1 mi)
· Sponsor: Jonsson Comprehensive Cancer Center
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,490 participants sought
Research Site — Los Angeles, California (29.1 mi)
· Sponsor: AstraZeneca
Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer
Prostate Adenocarcinoma, Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8
N/A
Interventional 45 participants sought
UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California (29.1 mi)
· Sponsor: Jonsson Comprehensive Cancer Center
Multi-Center Clean Air Randomized Controlled Trial in COPD
Chronic Obstructive Pulmonary Disease (COPD)
Phase 3
Interventional 770 participants sought
University of California, Los Angeles — Los Angeles, California (29.1 mi)
· Sponsor: JHSPH Center for Clinical Trials